CD4 and neoplasm: Nakajima et al. reported that MHC class II-restricted, WT1 protein-derived helper epitopes—WT135, WT186, and WT1294 for WT1-speicific CD4+ T cells—play an essential role in WT1-specific tumor immunity in in vivo mouse models [15].